Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.6% | −4.7% | −5.7% | −13.0% | +18.3% | +25.7% | +104.5% | +14.8% | +129.1% | +790.2% |
| Peer average | −1.5% | −5.1% | −2.8% | −5.1% | +15.0% | +19.1% | +61.3% | +21.3% | +153.6% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$23 of every $1,000 in XBI is Moderna
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 2.26% | $226.22 | 1.1M | $220.7M |
| 2 | TGTXTG Therapeutics | Healthcare | 1.89% | $188.89 | 2.8M | $184.3M |
| 3 | BIIBBiogen | Healthcare | 1.86% | $185.94 | 717K | $181.4M |
| 4 | EXELExelixis | Healthcare | 1.83% | $182.78 | 2.6M | $178.3M |
| 5 | REGNRegeneron Pharmaceuticals | Healthcare | 1.83% | $182.77 | 188K | $178.3M |
| 6 | SYRESpyre Therapeutics | Healthcare | 1.82% | $182.21 | 1.7M | $177.8M |
| 7 | GILDGilead Sciences | Healthcare | 1.81% | $181.13 | 1.0M | $176.7M |
| 8 | ABBVAbbvie | Healthcare | 1.78% | $177.67 | 603K | $173.3M |
| 9 | UTHRUnited Therapeutics | Healthcare | 1.78% | $177.55 | 298K | $173.2M |
| 10 | AMGNAmgen | Healthcare | 1.77% | $176.82 | 386K | $172.5M |
| 11 | NBIXNeurocrine Biosciences | Healthcare | 1.64% | $163.89 | 976K | $159.9M |
| 12 | ORKAOruka Therapeutics | Healthcare | 1.63% | $163.35 | 1.7M | $159.4M |
| 13 | ALKSAlkermes | Healthcare | 1.61% | $161.11 | 3.3M | $157.2M |
| 14 | VRTXVertex Pharmaceuticals | Healthcare | 1.61% | $160.73 | 291K | $156.8M |
| 15 | BBIOBridgebio Pharma | Healthcare | 1.60% | $160.08 | 2.0M | $156.2M |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 2.26% |
| 2 | TGTX | TG Therapeutics | 1.89% |
| 3 | BIIB | Biogen | 1.86% |
| 4 | EXEL | Exelixis | 1.83% |
| 5 | REGN | Regeneron Pharmaceuticals | 1.83% |
| 6 | SYRE | Spyre Therapeutics | 1.82% |
| 7 | GILD | Gilead Sciences | 1.81% |
| 8 | ABBV | Abbvie | 1.78% |
| 9 | UTHR | United Therapeutics | 1.78% |
| 10 | AMGN | Amgen | 1.77% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 22, 2026 | Jun 24, 2026 | $0.14 |
| Dec 22, 2025 | Dec 24, 2025 | $0.41 |
| Sep 22, 2025 | Sep 24, 2025 | $0.0267 |
| Jun 23, 2025 | Jun 25, 2025 | $0.0073 |
| Mar 24, 2025 | Mar 26, 2025 | $0.0053 |
| Dec 23, 2024 | Dec 26, 2024 | $0.0027 |
| Sep 23, 2024 | Sep 25, 2024 | $0.0152 |
| Jun 24, 2024 | Jun 26, 2024 | $0.11 |
| Dec 18, 2023 | Dec 21, 2023 | $0.0139 |
| Jun 20, 2023 | Jun 23, 2023 | $0.0026 |
| Mar 22, 2021 | Mar 25, 2021 | $0.0400 |
| Dec 21, 2020 | Dec 24, 2020 | $0.18 |